Abemaciclib, sold under the brand name Verzenio among others, is a medication developed by Eli Lilly for the treatment of advanced or metastatic breast cancers, specifically HR-positive, HER2-negative breast cancer. It works as a CDK inhibitor, selectively targeting CDK4 and CDK6, proteins that are crucial in promoting the growth and division of cancer cells. By inhibiting these kinases, abemaciclib helps slow or stop the progression of cancer.
Parent: Abemaciclib
![N-(5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine](https://veeprho.com/wp-content/uploads/2024/11/VE0022182-N-5-4-Ethylpiperazin-1-yl-methyl-pyridin.png "N-(5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine")
Parent: Abemaciclib
![N-[5-[(4-ethyl-1-oxidopiperazin-1-ium-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine](https://veeprho.com/wp-content/uploads/2026/10/N-5-4-ethyl-1-oxidopiperazin-1-ium-1-ylmethyl-2-pyridinyl-5-fluoro-4-7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-ylpyrimidin-2-amine-NA-VZA000044.png "N-[5-[(4-ethyl-1-oxidopiperazin-1-ium-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine")
Parent: Abemaciclib
![N-[5-[(4-ethyl-4-oxidopiperazin-4-ium-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine](https://veeprho.com/wp-content/uploads/2026/10/N-5-4-ethyl-4-oxidopiperazin-4-ium-1-ylmethyl-2-pyridinyl-5-fluoro-4-7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-ylpyrimidin-2-amine-NA-VZA000043.png "N-[5-[(4-ethyl-4-oxidopiperazin-4-ium-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine")
Parent: Abemaciclib
Parent: Abemaciclib
![1-Ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methyl)piperazine 1,4-dioxide](https://veeprho.com/wp-content/uploads/2026/10/1-Ethyl-4-6-5-fluoro-4-4-fluoro-1-isopropyl-2-methyl-1H-benzodimidazol-6-ylpyrimidin-2-ylaminopyridin-3-ylmethylpiperazine-14-dioxide-NA-VZA000034.png "1-Ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methyl)piperazine 1,4-dioxide")
Parent: Abemaciclib
![1-ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1-oxide](https://veeprho.com/wp-content/uploads/2024/11/VE0022184-1-ethyl-4-6-5-fluoro-4-4-fluoro-1-isopropyl-2.png "1-ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1-oxide")
Parent: Abemaciclib
![1-Ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1,4-dioxide](https://veeprho.com/wp-content/uploads/2024/11/VE0022183-1-Ethyl-4-6-5-fluoro-4-4-fluoro.png "1-Ethyl-4-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1,4-dioxide")
Parent: Abemaciclib
![4-Ethyl-1-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1-oxide](https://veeprho.com/wp-content/uploads/2024/11/VE0022185-4-Ethyl-1-6-5-fluoro-4.png "4-Ethyl-1-((6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)methyl)pyridin-3-yl)methyl)piperazine 1-oxide")
Parent: Abemaciclib
![4-Fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl) Boronic acid](https://veeprho.com/wp-content/uploads/2025/06/VE0024586-4-Fluoro-1-isopropyl-2-methyl-1H-benzo-d-imidazole-6-yl-Boronic-acid.png "4-Fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl) Boronic acid")
Parent: Abemaciclib
Parent: Abemaciclib
Parent: Abemaciclib
![5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)-N-(5-(piperazin-1-ylmethyl)pyridin-2-yl)pyrimidin-2-amine](https://veeprho.com/wp-content/uploads/2024/11/VE0022186-5-Fluoro-4-4-fluoro-1-isopropyl-2-methyl-1H-benzo-d-imidazol-6.png "5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)-N-(5-(piperazin-1-ylmethyl)pyridin-2-yl)pyrimidin-2-amine")
Parent: Abemaciclib
![6-((5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)nicotinic Acid](https://veeprho.com/wp-content/uploads/2026/10/6-5-Fluoro-4-4-fluoro-1-isopropyl-2-methyl-1H-benzodimidazol-6-ylpyrimidin-2-ylaminonicotinic-Acid-NA-VZA000033.png "6-((5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)nicotinic Acid")
Parent: Abemaciclib
![6-(2-chloro-5-fluoropyrimidin-4-yl)-1-isopropyl-2-methyl-1H-benzo[d]imidazole](https://veeprho.com/wp-content/uploads/2024/11/VE0022180-6-2-chloro-5-fluoropyrimidin-4-yl.png "6-(2-chloro-5-fluoropyrimidin-4-yl)-1-isopropyl-2-methyl-1H-benzo[d]imidazole")
Parent: Abemaciclib
![6-(2-Chloropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole](https://veeprho.com/wp-content/uploads/2024/11/VE0022181-6-2-Chloropyrimidin-4-yl-4-fluoro-1-isopropyl-2-methyl.png "6-(2-Chloropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole")
Parent: Abemaciclib
![6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]pyridine-3-carbaldehyde](https://veeprho.com/wp-content/uploads/2026/10/6-5-fluoro-4-7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-ylpyrimidin-2-ylaminopyridine-3-carbaldehyde-1627082-92-1-VZA000032.png "6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]pyridine-3-carbaldehyde")
Parent: Abemaciclib
During the production and storage of abemaciclib, impurities may develop that need to be closely monitored to ensure the medication’s safety and efficacy. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) establish strict guidelines for allowable impurity levels in pharmaceutical products to protect patient health.
No, abemaciclib is not like traditional chemotherapy. Unlike chemotherapy, which kills rapidly dividing cells, abemaciclib is a targeted therapy that inhibits CDK4 and CDK6. This selective action helps slow cancer cell growth with fewer side effects compared to chemotherapy, though side effects may still occur.
Abemaciclib works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), proteins that are involved in cell division. By blocking these kinases, abemaciclib helps to slow the growth of cancer cells, particularly in patients with HR-positive, HER2-negative breast cancer.
Abemaciclib blocks CDK4 and CDK6, which are enzymes that drive the cell cycle in cancer cells. By inhibiting these kinases, abemaciclib prevents cancer cells from advancing through the cell division cycle, reducing their ability to grow and spread.
Yes, abemaciclib is a CDK inhibitor, specifically targeting CDK4 and CDK6. This selective inhibition makes it effective in controlling the proliferation of cancer cells in certain types of breast cancer.
